FIELD: biotechnologies.
SUBSTANCE: compound is proposed with a formula
specified below, or its pharmaceutically acceptable salt, representing a nystatin derivative, having an additional double link, available between C28 and C29, and additionally modified relative to nystatin according to position C16. These compounds are used as antifungal agents. Also in the invention a pharmaceutical composition is announced, and its manufacturing to treat fungal infections, as well as the method to treat a fungal infection of an animal, including introduction of an efficient compound dose to the specified animal.
EFFECT: improved efficiency of compound application.
10 cl, 29 ex, 17 dwg, 15 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING ANTIFUNGAL SEMISYNTHETIC POLYENE ANTIBIOTIC | 2020 |
|
RU2751333C1 |
| NATAMYCIN AMIDES AND THEIR USE FOR THE TREATMENT OF FUNGAL INFECTIONS | 2022 |
|
RU2803742C1 |
| ANTIFUNGAL SEMI-SYNTHETIC POLYENE ANTIBIOTIC, WATER-SOLUBLE SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2018 |
|
RU2688658C1 |
| PROCESS FOR PRODUCING METHYLSULFATES OF N,N,N=TRIMETHYLAMMONIUM DERIVATIDES OF POLYENE MACROLYDES | 0 |
|
SU955855A3 |
| INHIBITORS OF VIIA FACTOR | 1999 |
|
RU2223967C2 |
| SYNTHETIC PEPTIDES REDUCING OR ELIMINATING BAGGY LOWER EYELIDS, AND APPLICATION THEREOF IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS | 2005 |
|
RU2387666C2 |
| PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY | 2018 |
|
RU2807076C2 |
| PTH-COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEIR, DNA FRAGMENT AND FUSED PROTEIN | 1993 |
|
RU2130945C1 |
| OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
| HEMIN-PEPTIDES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND USING AS ANTI-TUMOR AGENTS | 2004 |
|
RU2280649C1 |
